Risk factor
Very poor trading liquidity
Profitability factor
Favourable analyst view
About
MPH Health Care AG, an investment company, engages in the healthcare business in Germany. It produces and sells medicinal products for the therapies of cancer, HIV, and other chronic diseases. The company also offers medical aesthetic treatments; and develops and sells pharmaceutical and medical products; and provides related services, as well as medical devices for...
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is neutral on EV/EBITDA, overpriced on P/FC
Target Price
The average target price of 93M1.DE is 37 and suggests 54% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
Buy
Sell